XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.4
Common Stock, Stock Options and Warrants (Details) - Schedule of Option Activity Under Our Stock Option Plans - USD ($)
 12 Months Ended
Sep. 30, 2023
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Option Shares, Outstanding Ending balance 532,207 656,084
Weighted- Average Exercise Price, Outstanding Ending balance (in Dollars per share) $ 44.75 $ 36.41
Weighted- Average Remaining Contractual Term, Outstanding Ending balance 7 years 4 months 28 days 7 years 3 months 3 days
Aggregate Intrinsic Value, Outstanding Ending balance (in Dollars) $ 56,203 $ 0
Exercisable at September 30, 2024   347,618
Exercisable at September 30, 2024 (in Dollars per share)   $ 44.4
Exercisable at September 30, 2024   6 years 3 months 7 days
Exercisable at September 30, 2024 (in Dollars)   $ 0
Option Shares, Granted   166,400
Weighted- Average Exercise Price, Granted (in Dollars per share)   $ 17.5
Weighted- Average Remaining Contractual Term, Granted   9 years 14 days
Aggregate Intrinsic Value, Granted (in Dollars)   $ 0
Option Shares, Exercised   (2,125)
Weighted- Average Exercise Price, Exercised (in Dollars per share)   $ 0.38
Exercised, Aggregate Intrinsic Value (in Dollars)   $ 39,068
Option Shares, Forfeited or expired   (40,398)
Weighted- Average Exercise Price, Forfeited or expired (in Dollars per share)   $ 68.5
Citius Oncology [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Option Shares, Outstanding Ending balance 12,600,000 12,750,000
Weighted- Average Exercise Price, Outstanding Ending balance (in Dollars per share) $ 2.15 $ 2.15
Weighted- Average Remaining Contractual Term, Outstanding Ending balance 9 years 9 months 7 days 8 years 9 months 10 days
Aggregate Intrinsic Value, Outstanding Ending balance (in Dollars)
Exercisable at September 30, 2024   3,937,500
Exercisable at September 30, 2024 (in Dollars per share)   $ 2.15
Exercisable at September 30, 2024   8 years 9 months 7 days
Exercisable at September 30, 2024 (in Dollars)  
Option Shares, Granted   150,000
Weighted- Average Exercise Price, Granted (in Dollars per share)   $ 2.15
Option Shares, Forfeited or expired